Table 1.

Patient Characteristics

Characteristics	No. of Patients	%
Gender
Male	4	33.3
Female	8	66.7
Age, years
Median	52
Range	33–64
Primary site
Acral	5	41.6
Mucosal	4	33.3
Conjunctiva	1	8.3
Unknown primary	2	16.7
Metastatic sites
Distant lymph node only	2	16.7
Lung only	2	16.7
Liver	3	25.0
Bone	4	33.3
Other sites	2	16.7
BRAF mutation	1	8.3
Previous therapy
BRAF inhibitor	1	8.3
Immunotherapy	9	75.0
Chemotherapy	9	75.0
Containing DTIC	2	16.7
Not Containing DTIC	7	58.3

DTIC, dacarbazine.